LEVETIRACETAM

LEVETIRACETAM
Es una droga usada para el tratamiento de la epilepsia, disminuye la hiperactividad hipocampal en pacientes con deterioro cognitivo amnéstico y puede probar ser útil en prevenir o enlentecer la progresión a la enfermedad de Alzheimer.
La hiperactividad hipocampal contribuye a problemas de memoria, han descubierto que dosis muy bajas fueron útiles para controlar la hiperactividad (Gallager M. 2011).   

   

 

BIBLIOGRAFIA

    ALAMO C., LÓPEZ MUÑOZ F., GUERRA J.A. Bases Neurobiológicas del empleo de antiepilépticos en el trastorno bipolar. Actas Esp Psiquiatr 2008;36(Suppl-3):3-21.

    ANDERSON P.  I. Utero Exposure to Antiepileptic Drugs Affects Teen School Performance. Epilepsia on line November 4, 2010. Medscape Psychiatry & Mental Health. November 4 2010.

BAZIRE S. Directorio de Fármacos Psicotrópicos 2000 Manual del Profesional. Quay Books. 1999. p. 287.

BOWDEN Ch. Et al. Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania. JAMA March 23/30, vol 271, Nº 12. 918-924. 1994.

  BROOKS S. and LESSIN B. Treatment of Resistant Lithium-Induced Nephrogenic Diabetes Insipidus and Schizoaffective Psychosis with Carbamazepine. American Journal of Psychiatry. 140: 1077-1078. August 1983.

 CHOUIRNARD G. et al. Antimanic Effect of Clonazepam. Biol. Psychiatry 18: 451-466. 1983.

    DÍAS MARSÁ M., TAJIMA K., MONTES A., CARRASCO J.,  Tratamiento  con fármacos anticommiciales de los trastornos de la personalidad. Actas Esp. Psiquiatr. 2008.36 (Suppl. 3): 39-45.

DICCIONARIO DE ESPECIALIDADES FARMACÉUTICAS. PDR 2009. p 81, 723, 724.

DOMENECH J. et al. Aspectos clínicos prácticos del uso de anticomiciales. Actas Esp. Psiquiatr 2008;36(Suppl. 3): 75-87

FLYGENRING J. et al. Treatment of Alcohol Withdrawal Symptoms in Hospitalized Patients. Acta Psychiatrica Scandi­navica. 69: 398-408. 1984.

 FOLKS D. et al. Carbamazepine Treatment of Selected Affectively Disordered Impatients. American Journal of Psychiatry. 139: 1: January 1982.

 FONTAINE R. and CHOUINARD G. Antipanic Effect of Clonaze­pam (letter). American Journal of Psychiatry. 141: 149. 1984.

FREEMAN M. and STOLL A. Mood Stabilizer Combinations: A Review of Safety and Efficacy. American J, of Psychiatry 155, 1:12-21, January 1998.

    GALLAGER M. EISEN K. Levetiracetam May Slow Progression to Alzheimer´s. July 26. 2011. Medscape Medical News. Alzheimer’s Association International Conference June 20  2011. http://www.medscape.com/viewarticle/747019?src=mpnewsspon=12
Medscape Psychiatry and Mental Health.

   GARBUTT J. and LOOSEN P. Is Carbamazepine Helpful in Paroxismal Behaviour Disorders?. American Journal of Psychiatry. 140: 1363-1364. 1983.
   HART R. y EASTON J. Carbamazepine and Hematologic Monito­ring. Ann. Neurol. 11: 309-312. 1982.

    HERNÁNDEZ DE GONZÁLEZ MARÍA  Efecto Neuroprotector del Ácido Valproico en la Isquemia-Reperfusión. Universidad Centro Occidental Lisandro Alvarado. Barquisimeto 2007.
http://bibmed.ucla.edu.ve/edocs_bmucla/textocompleto/TQV126DV4H47e2006.pdf

    HOLLANDER E. WONG CH. Conceptos Actuales en el Diagnóstico y Tratamiento de los Trastornos Psiquiátricos Frecuentes. Segunda Edición. Handbooks in Health Care Co. 2007. pp. 90,104.

    ÍNDICE DE DROGAS. http://ar.geocites.com/indicadores/valproico.htm

JANICAK P. DAVIS J. PRESKORN S. AYD F. Principles and Practice of Psychopharmacotherapy. Williams & Wilkins. 1993. pp 13, 114, 115, 152, 216, 286, 287, 329, 342, 344, 346, 370, 374, 380, 382, 396, 399, 401, 402, 438, 458, 477, 483, 497, 498, 508.

    JEFFREY S. FDA Warns of Cognitive Delay in Offspring With Valproate. http://www.medscape.com/viewarticle/745669?src=mpnews&spon=12
June 30. 2011_FDA.

    JUFE G. Psicofarmacología práctica. Buenos Aires, Editorial Polemos, 2001.

   KARSON C. and al. Clonazepam Treatment of Chronic Schi-zophrenia: Negative Results in a Double-Blind Placebo-Controlled Trial. American Journal of Psychiatry. 139: 12: 1627-1628. December 1982.

 KISHIMOTO A. et al. Long-term Prophylactic Effects of Carbamazepine in Affective Disorder. British Journal of Psychiatry. 143: 327-331. 1983.

   KLEIN E. et al. Carbamazepine and Haloperidol vs Placebo and Haloperidol in Excited Psychoses; A Controlled Study. Archives General Psychiatry. 41: 165-170. February 1984.

   LINDHOUT D. y col. Teratogenicity of Antiepileptic Drug Conbinations with Special Emphasis on Epoxidation (of Carba­mazepine). Epilepsia. 1984. 25. 77-83.

 LIPINSKI J. and POPE H. Possible Synergistic Action Between Carbamazepine and Lithium Carbonate in the Treatment of Three Acutely Manic Patients. American Journal of Psychiatry. 139: 7: 948-949. July 1982.

   LUCHINS D. Fatal Agranulocytosis in a Chronic Schizophrenic Patient Treated with Carbamazepine. American Journal of Psychiatry. 141: 687-688. 1984.

   LUSZNAT R. et al. Carbamazepine vs Lithium in the Treat­ment and Profilaxis of Mania. British Journal of Psychiatry. 153: 198-204. 1988.

   MALCOM R. et al. Double-Blind Controlled Trial Comparing Carbamazepine to Oxazepam Treatment of Alcohol Withdrawal. American Journal of Psychiatry. 146: 5: 617-621. May 1989.

    MEADOR K. FDA Issues Alert of Cognitive Delay in Infants Exposed to Valproate. New England Journal of Medicine 2009. http://www.medscape.org/viewarticle/746173?src=cmemp

   MILLER D. and MACKLIN M. Cimetidine-Imipramine Inte-raction: A Case Report. American Journal of Psychiatry, 140: 351-352, 1983.

    MOLGAARD-NIELSEN. May 18. Journal of American Medical Association. JAMA 2011; 305: 1996-2002.
http://www.medscape.org/viewarticle/743096?src=cmemp
Medscape Psychiatry & Mental Health New Antiepileptics Drugs May Not Increase Birth Defect Risk. 05/20/2011.

   OKUMA T. Antimanic and Profylactic Effects of Carbamaze­pine on Manic-depressive Psychosis. Folia Psyco. Neurol. Jpn. 27: 283-297. 1973.

    PONCE G., RODRÍGUEZ JIMÉNEZ R., Uso de antiepilépticos en adicciones. Actas Esp Psiquiatr. 2008; 36(suppl.3): 22-27.

    POPE et al. Valproate in the Treatment of Acute Mania. Arch. Gen. Psychiatry-vol 48. 62-68. January 1991.

   POST R. et al. Kindling and Carbamazepine in Affective Illness. Journal of Nervous and Mental Disease. 170: 12: 717-731. 1982.

   POST R. Prophylactic Efficacy of Carbamazepine in Manic-Depressive Illness. American Journal of Psychiatry. 140: 1602-1604. 1983.

    POST R. et al. Carbamacepine and its-10, 11-epoxide Me-tabolite in Plasma and CSF: Relationship to Antidepressant Response. Archives General Psychiatry. 40: 673-676. 1983.

   POST R. et al. Profile of Clinical Efficacy and Side Effects of Carbamazepine in Psychiatric Illness: Relation-ship to Blood and CSF Levels of Carbamazepine and its -10-11-epoxide Metabolite. Acta Psychiatrica Scandinavica; Supplementum Nº313. 69: 104-117. 1984.

    POST R. et al. Re-evaluating carbamazepine prophylaxis in bipolar disorder. British J of Psychiatry, 170,202-204, 1997.

   RALL T. y SCHLEIFER L. Drogas Efectivas para el Trata-miento de la Epilepsia. Las Bases Farmacológicas de la Terapéutica. Séptima Edición. Editado por Goodman A., Good­man L., Rall T., Murad F..Editorial Médica Panamericana. 1986.

   REINOLDS E. Mental Effects of Antiepileptic Medication: A Review. Epilepsia. 24(Suppl.2): 585-595. Raven Press, New York. 1983.

    ANDERSON F., SCHADE R., WILLICK S., GARBE E., Use of antiepileptics drugs  in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010; 75: 335-340. American Academy of Neurology. http://www.neurologia.com/sec/RSS/noticias.php?idNoticia=2371  

   ROY-BYRNE P. et al. Carbamazepine and Thyroid Function in Affectively Ill Patients. Clinical and Theoretical Implica­tions. Archives General psychiatry. 41: 1150-1153. Dec 1983.

   ROY-BYRNE P. et al. Relationship of Response to Sleep Deprivation and Carbamazepine in Depressed Patients. Acta Psychiatrica Scandinavica. 69: 379-382. 1984.

   SYMPOSIUM (various authors) Epilepsy: Diagnosis and Management. (Browne, T. and Feldman R. eds.) Little, Brown and Co., Boston 1983.

   TAKEZAKI H. The Use of Carbamazepine in the Control of Manic-depressive States. J. Clinic Psychiatry 13: 173-183,     1971.

    TARIOT P. et al. Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia. American J. Psychiatry 155:1:54-61, January 1998.

    TARIOT P. SCHNEIDER L. CUMMINGS J. y otros Can Valproate Delay Alzheimer´s Disease? http://medscape.com/viewarticle/747872?src=mpnews&spon=12  Arch. Gen. Psychiatry. 2011: 68: 853-861

    Triple i. Central Nervous System Precribing Guide. WINTER/SPRING 2005.p. 89.

    VADEMECUM Ácido Valproico. http://www.iqb.es/cbasicas/farma/farma04/v002.htm  

   VICTOR B. et al. Use of Clonazepam in Mania and Schizoaffective Disorders. American Journal of Psychiatry. 141: 1111-1112. 1984.
WEILER M.  y col. Sobredosis de Drogas Psicotrópicas. Psiquiatría Diagnóstico y Tratamiento. Editado por Flaherty-Channon-Davis. Editorial Médica Panamericana. 1991.

    WIKINSKI S. JUFE G. El tratamiento Farmacológico en Psiquiatría. Editorial Médica Panamericana.2005. pp 71, 79, 185, 186, 187. 279, 286.

 


Menu Principal
Perfil Profesional
Psiquiatria Forense
Psiquiatría de Enlace
Psiquiatría Para Estudiantes de Médicina
Prevalencia de las Disquinecias Tardías
Uso De Sustancias Adictivas En Pacientes De Psiquiatría De Enlace
Terapias Biológicas En Psiquiatría
Algunos Trabajos Tutoreados (Resumenes)
Tesis - Riesgo Suicida en los Médicos Cursantes de Postgrado en el Instituto Autónomo HULA
Tesis - Incidencia de Déficit Cognitivo y Demencia en pacientes sometidos a Reanimación Cerebro...
Tesis - Trastorno De Personalidad En Consumidores Compulsivos De Heroína Y Crack. Fundación José ...
Tesis - Sindrome de Desgaste Profesional en Estudiantes de Postgrado HULA


 






©Sanliz 2008